Presentation Theater: An Evidence Based Approach for Considering Biosimilars in Appropriate Patients

Description

  • Understand the goals of biosimilars in the United States
  • Discuss how the FDA evaluates biosimilars
  • Consider the “totality-of-the-evidence” supporting approval for biosimilars

Speaker: Christopher Fourment, MD

Presented by Merck & Co., Inc.

 
 
 
Interest: Presentation Theater
Session Time Slot(s): 
Date: 
Tuesday, October 29
Time: 
1:00 PM - 2:00 PM
Room: 
Hilton Anatole Dallas - Trinity Exhibit Hall